Accelerate Diagnostics
AXDX
AXDX was delisted on the 14th of May, 2025.
92 hedge funds and large institutions have $271M invested in Accelerate Diagnostics in 2016 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 47 increasing their positions, 15 reducing their positions, and 19 closing their positions.
213% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 15
23% more call options, than puts
Call options by funds: $1.39M | Put options by funds: $1.13M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 97 → 92 (-5)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
34% less capital invested
Capital invested by funds: $413M → $271M (-$142M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
William Blair Investment Management
Chicago,
Illinois
|
+$1.93M |
| 2 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
+$1.56M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$1.37M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.12M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.07M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$8.55M |
| 2 |
MGM
Miura Global Management
New York
|
-$7.06M |
| 3 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$3.41M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.82M |
| 5 |
DA
DSC Advisors
Chicago,
Illinois
|
-$2.45M |
AXDX Hedge Fund Activity: Q1 2016 in Review
92 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q1 2016, worth a combined $271M — down 34% from $413M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of AXDX and 16 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 47 added.
The largest buyer was William Blair Investment Management, adding an estimated $1.93M. The largest seller was Oracle Investment Management, cutting an estimated $8.55M.
- 92 institutional investors held Accelerate Diagnostics (AXDX) as of Q1 2016, down from 97 in Q4 2015.
- Funds reported $271M of Accelerate Diagnostics stock for Q1 2016, down 34% quarter-over-quarter.
- 16 funds opened new Accelerate Diagnostics positions in Q1 2016 and 19 closed out, a net change of -3 holders.
- The largest Accelerate Diagnostics buyer in Q1 2016 was William Blair Investment Management, an estimated $1.93M added.
- The largest Accelerate Diagnostics seller in Q1 2016 was Oracle Investment Management, an estimated $8.55M sold.
Based on aggregated 13F filings for Q1 2016.